Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Repower Asia Indonesia Tbk. (REAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Repower Asia Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Repower Asia Indonesia Tbk. trades at Rp51 (market cap 331.68B, 83.39M 24h volume). The key difference: Repower Asia Indonesia Tbk. is the larger of the two by market cap, and Repower Asia Indonesia Tbk. is more actively traded (83.39M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | REAL | |
|---|---|---|
Market Cap | 172.82B | 331.68B |
Volume | 592.2K | 83.39M |
Lot | 5.92K | 833.87K |
Turnover | 147.05M | 4.25B |
Average Price | 248.31 | 51.02 |
Value | 147.05M | 4.25B |
Indicative Equilibrium Price | 254 | 51 |
Indicative Equilibrium Volume | 10 | 5.57K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Repower Asia Indonesia Tbk.
PT Repower Asia Indonesia Tbk (the Company) was established based on Notarial Deed No. 04 of Titik Krisna Murti Wikaningsih, S.H., M.KN., dated March 13, 2011, a Notary in Bekasi.
Read more on REAL →
